.png)
Together, we are building a clearer understanding of your brain health journey while informing you about your clinical trial options investigating new drugs for Alzheimer's.
gives back to you
Research That
UPCOMING EXPERT TALK
Learning from Innate Resilience to Alzheimer's Disease
Join us for a conversation with the leading experts on the latest science, practical insights, and what it means for people and families today.
Sept 29, 2026 • 2:00 PM PT • Live Q&A
ABOUT ADRI
Join the Alzheimer's Disease Research Initiative
Listen to Dr. O’Bryant, Executive Director of the Institute for Translational Research at UNT Health and a leading global expert in Alzheimer’s disease.
WHAT IS ADRI?
ADRI is a virtual research initiative that connects people living with Alzheimer's, families, caregivers, and researchers to accelerate breakthroughs in detection, treatment, and care.
30 minutes every 3 months
Participate from home
Personalized insights
Follow changes over time through your research participation
.png){kind=small}
Advance Alzheimer's research
Your participation helps researchers better understand the disease
Just 2 hours from home
Only 30 minutes every 3 months
Secure & Private
Your data is encrypted
and protected.
Research That Benefits You
Your participation helps
drive real progress.
TOGETHER, WE CAN ACCELERATE ALZHEIMER'S RESEARCH
Join EverythingALZ Research
Tell us a little about yourself so we can guide you to the most relevant research opportunities.
Join EverythingALZ Research
Create your account and tell us a little about yourself.
Build Your Baseline
Complete simple assessments from home to establish your personal baseline.
Track Over Time
30 minutes every 3 months to track changes and gain personalized insights.
Personalize Clinical Trials
We use SAVA Al and your data to match you to clinical trials that may be right for you.
_edited.png){kind=small}
BUILT ON A PROVEN MODEL IN ALS
Experience that powers our approach.
EverythingALZ builds on the proven citizen-driven research model and technology developed through EverythingALS.
1,700+
Participants engaged
24
Industry partners
14+
Active studies
12+
Academic partners
5TB+
Data collected (multimodal)
50
US states
represented